
Nicole Erin Kinsey White
Examiner (ID: 18489, Phone: (571)272-9943 , Office: P/1648 )
| Most Active Art Unit | 1648 |
| Art Unit(s) | 1671, 1672, 1648 |
| Total Applications | 1130 |
| Issued Applications | 560 |
| Pending Applications | 136 |
| Abandoned Applications | 472 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 6595278
[patent_doc_number] => 20100062462
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-03-11
[patent_title] => 'IMMUNODEFICIENCY VIRUSES'
[patent_app_type] => utility
[patent_app_number] => 12/097473
[patent_app_country] => US
[patent_app_date] => 2006-12-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 21
[patent_figures_cnt] => 21
[patent_no_of_words] => 12784
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0062/20100062462.pdf
[firstpage_image] =>[orig_patent_app_number] => 12097473
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/097473 | IMMUNODEFICIENCY VIRUSES | Dec 13, 2006 | Abandoned |
Array
(
[id] => 5219309
[patent_doc_number] => 20070160620
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-07-12
[patent_title] => 'Immune responses using compositions containing stress proteins'
[patent_app_type] => utility
[patent_app_number] => 11/635410
[patent_app_country] => US
[patent_app_date] => 2006-12-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 14255
[patent_no_of_claims] => 2
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0160/20070160620.pdf
[firstpage_image] =>[orig_patent_app_number] => 11635410
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/635410 | Immune responses using compositions containing stress proteins | Dec 6, 2006 | Abandoned |
Array
(
[id] => 5005752
[patent_doc_number] => 20070203325
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-08-30
[patent_title] => 'Integrase-dirived HIV-inhibiting agents'
[patent_app_type] => utility
[patent_app_number] => 11/606904
[patent_app_country] => US
[patent_app_date] => 2006-12-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 41
[patent_figures_cnt] => 41
[patent_no_of_words] => 28662
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0203/20070203325.pdf
[firstpage_image] =>[orig_patent_app_number] => 11606904
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/606904 | Integrase-dirived HIV-inhibiting agents | Nov 30, 2006 | Abandoned |
Array
(
[id] => 5434995
[patent_doc_number] => 20090169581
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-07-02
[patent_title] => 'STABILIZING FORMULATIONS FOR RECOMBINANT VIRUSES'
[patent_app_type] => utility
[patent_app_number] => 12/094302
[patent_app_country] => US
[patent_app_date] => 2006-11-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 5897
[patent_no_of_claims] => 40
[patent_no_of_ind_claims] => 19
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0169/20090169581.pdf
[firstpage_image] =>[orig_patent_app_number] => 12094302
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/094302 | STABILIZING FORMULATIONS FOR RECOMBINANT VIRUSES | Nov 14, 2006 | Abandoned |
Array
(
[id] => 4970766
[patent_doc_number] => 20070110768
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-05-17
[patent_title] => 'Use of histones for the early diagnosis and/or preventive therapy of virally-infected living cells and a biochip for carrying out said diagnosis'
[patent_app_type] => utility
[patent_app_number] => 11/594983
[patent_app_country] => US
[patent_app_date] => 2006-11-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2740
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0110/20070110768.pdf
[firstpage_image] =>[orig_patent_app_number] => 11594983
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/594983 | Use of histones for the early diagnosis and/or preventive therapy of virally-infected living cells and a biochip for carrying out said diagnosis | Nov 8, 2006 | Abandoned |
Array
(
[id] => 856615
[patent_doc_number] => 07374872
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2008-05-20
[patent_title] => 'CC chemokine receptor 5 DNA, new animal models and therapeutic agents for HIV infection'
[patent_app_type] => utility
[patent_app_number] => 11/594375
[patent_app_country] => US
[patent_app_date] => 2006-11-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 20643
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 40
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/374/07374872.pdf
[firstpage_image] =>[orig_patent_app_number] => 11594375
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/594375 | CC chemokine receptor 5 DNA, new animal models and therapeutic agents for HIV infection | Nov 6, 2006 | Issued |
Array
(
[id] => 5148228
[patent_doc_number] => 20070048287
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-03-01
[patent_title] => 'Molecular antigen array'
[patent_app_type] => utility
[patent_app_number] => 11/592127
[patent_app_country] => US
[patent_app_date] => 2006-11-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 54
[patent_figures_cnt] => 54
[patent_no_of_words] => 86042
[patent_no_of_claims] => 52
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0048/20070048287.pdf
[firstpage_image] =>[orig_patent_app_number] => 11592127
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/592127 | Molecular antigen array | Nov 2, 2006 | Abandoned |
Array
(
[id] => 5259122
[patent_doc_number] => 20070212754
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-09-13
[patent_title] => 'Hepatitis C Virus NS2/3 Activity Assay'
[patent_app_type] => utility
[patent_app_number] => 11/553531
[patent_app_country] => US
[patent_app_date] => 2006-10-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 7771
[patent_no_of_claims] => 30
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0212/20070212754.pdf
[firstpage_image] =>[orig_patent_app_number] => 11553531
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/553531 | Hepatitis C virus NS2/3 activity assay | Oct 26, 2006 | Issued |
Array
(
[id] => 5107920
[patent_doc_number] => 20070066798
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-03-22
[patent_title] => 'Diagnostic and therapeutic use of antibodies against the urokinase receptor'
[patent_app_type] => utility
[patent_app_number] => 11/586579
[patent_app_country] => US
[patent_app_date] => 2006-10-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 15
[patent_figures_cnt] => 15
[patent_no_of_words] => 5184
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0066/20070066798.pdf
[firstpage_image] =>[orig_patent_app_number] => 11586579
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/586579 | Diagnostic and therapeutic use of antibodies against the urokinase receptor | Oct 25, 2006 | Issued |
Array
(
[id] => 4915198
[patent_doc_number] => 20080095798
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-04-24
[patent_title] => 'Ii-key enhanced vaccine potency'
[patent_app_type] => utility
[patent_app_number] => 11/582596
[patent_app_country] => US
[patent_app_date] => 2006-10-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 11999
[patent_no_of_claims] => 32
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0095/20080095798.pdf
[firstpage_image] =>[orig_patent_app_number] => 11582596
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/582596 | Ii-key enhanced vaccine potency | Oct 17, 2006 | Abandoned |
Array
(
[id] => 5539135
[patent_doc_number] => 20090220940
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-09-03
[patent_title] => 'Method for Testing the Integrity of Membranes'
[patent_app_type] => utility
[patent_app_number] => 12/083600
[patent_app_country] => US
[patent_app_date] => 2006-10-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 10300
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0220/20090220940.pdf
[firstpage_image] =>[orig_patent_app_number] => 12083600
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/083600 | Method for Testing the Integrity of Membranes | Oct 16, 2006 | Abandoned |
Array
(
[id] => 5397341
[patent_doc_number] => 20090317404
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-12-24
[patent_title] => 'REDUCTION AND PREVENTION OF CELL-ASSOCIATED HIV TRANSEPITHELIAL MIGRATION, MICROBIDES AND OTHER FORMULATIONS AND METHODS'
[patent_app_type] => utility
[patent_app_number] => 12/083582
[patent_app_country] => US
[patent_app_date] => 2006-10-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 18
[patent_figures_cnt] => 18
[patent_no_of_words] => 10013
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 8
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0317/20090317404.pdf
[firstpage_image] =>[orig_patent_app_number] => 12083582
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/083582 | REDUCTION AND PREVENTION OF CELL-ASSOCIATED HIV TRANSEPITHELIAL MIGRATION, MICROBIDES AND OTHER FORMULATIONS AND METHODS | Oct 12, 2006 | Abandoned |
Array
(
[id] => 5193875
[patent_doc_number] => 20070082359
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-04-12
[patent_title] => 'Methods for detecting compounds that interfere with protein aggregation utilizing an in vitro fluorescence-based assay'
[patent_app_type] => utility
[patent_app_number] => 11/546796
[patent_app_country] => US
[patent_app_date] => 2006-10-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 13051
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0082/20070082359.pdf
[firstpage_image] =>[orig_patent_app_number] => 11546796
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/546796 | Methods for detecting compounds that interfere with protein aggregation utilizing an in vitro fluorescence-based assay | Oct 11, 2006 | Issued |
Array
(
[id] => 5336715
[patent_doc_number] => 20090053179
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-02-26
[patent_title] => 'METHOD FOR USING LIBERATED DORMANT BACTERIOPHAGE AND ENVIRONMENTAL STRESS TO REDUCE INFECTIOUS BACTERIA'
[patent_app_type] => utility
[patent_app_number] => 12/088951
[patent_app_country] => US
[patent_app_date] => 2006-10-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 4465
[patent_no_of_claims] => 27
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0053/20090053179.pdf
[firstpage_image] =>[orig_patent_app_number] => 12088951
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/088951 | METHOD FOR USING LIBERATED DORMANT BACTERIOPHAGE AND ENVIRONMENTAL STRESS TO REDUCE INFECTIOUS BACTERIA | Oct 4, 2006 | Abandoned |
Array
(
[id] => 4976830
[patent_doc_number] => 20070218061
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-09-20
[patent_title] => 'Use of ephrinb2 directed agents for the treatment or prevention of viral infections'
[patent_app_type] => utility
[patent_app_number] => 11/527253
[patent_app_country] => US
[patent_app_date] => 2006-09-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 29
[patent_figures_cnt] => 29
[patent_no_of_words] => 27788
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0218/20070218061.pdf
[firstpage_image] =>[orig_patent_app_number] => 11527253
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/527253 | Use of ephrinb2 directed agents for the treatment or prevention of viral infections | Sep 24, 2006 | Abandoned |
Array
(
[id] => 4778759
[patent_doc_number] => 20080286757
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-11-20
[patent_title] => 'Method and Apparatus for Identification of Microorganisms Using Bacteriophage'
[patent_app_type] => utility
[patent_app_number] => 12/066806
[patent_app_country] => US
[patent_app_date] => 2006-09-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 7616
[patent_no_of_claims] => 28
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0286/20080286757.pdf
[firstpage_image] =>[orig_patent_app_number] => 12066806
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/066806 | Method and Apparatus for Identification of Microorganisms Using Bacteriophage | Sep 14, 2006 | Abandoned |
Array
(
[id] => 5056389
[patent_doc_number] => 20070059311
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-03-15
[patent_title] => 'Regulation of the hedgehog signaling pathway and uses thereof'
[patent_app_type] => utility
[patent_app_number] => 11/519531
[patent_app_country] => US
[patent_app_date] => 2006-09-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 14
[patent_figures_cnt] => 14
[patent_no_of_words] => 8483
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0059/20070059311.pdf
[firstpage_image] =>[orig_patent_app_number] => 11519531
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/519531 | Regulation of the hedgehog signaling pathway and uses thereof | Sep 11, 2006 | Abandoned |
Array
(
[id] => 5514263
[patent_doc_number] => 20090214569
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-08-27
[patent_title] => 'Use of HIV envelope/CD4 complexes for the generation antibodies'
[patent_app_type] => utility
[patent_app_number] => 11/990953
[patent_app_country] => US
[patent_app_date] => 2006-08-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 12082
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0214/20090214569.pdf
[firstpage_image] =>[orig_patent_app_number] => 11990953
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/990953 | Use of HIV envelope/CD4 complexes for the generation antibodies | Aug 24, 2006 | Abandoned |
Array
(
[id] => 5182588
[patent_doc_number] => 20070053934
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-03-08
[patent_title] => 'Polyvalent multimeric composition containing active polypeptides, pharmaceutical compositions and methods of using the same'
[patent_app_type] => utility
[patent_app_number] => 11/510493
[patent_app_country] => US
[patent_app_date] => 2006-08-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 29
[patent_figures_cnt] => 29
[patent_no_of_words] => 61044
[patent_no_of_claims] => 66
[patent_no_of_ind_claims] => 20
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0053/20070053934.pdf
[firstpage_image] =>[orig_patent_app_number] => 11510493
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/510493 | Polyvalent multimeric composition containing active polypeptides, pharmaceutical compositions and methods of using the same | Aug 24, 2006 | Abandoned |
Array
(
[id] => 5642673
[patent_doc_number] => 20060281128
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-12-14
[patent_title] => 'Compositions and methods using lentivirus-based vectors for generating immune responses'
[patent_app_type] => utility
[patent_app_number] => 11/506390
[patent_app_country] => US
[patent_app_date] => 2006-08-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 12175
[patent_no_of_claims] => 40
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0281/20060281128.pdf
[firstpage_image] =>[orig_patent_app_number] => 11506390
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/506390 | Compositions and methods using lentivirus-based vectors for generating immune responses | Aug 16, 2006 | Abandoned |